Carcinogenicity of lipid-lowering drugs

被引：0
|
作者：
Laws, A
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 275卷 / 19期
关键词：
D O I：
10.1001/jama.1996.03530430023027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1480 / 1480
页数：1
相关论文
共 50 条
  • [21] Lipid-lowering drugs and homocysteine
    de Lorgeril, M
    Salen, P
    Paillard, F
    Lacan, P
    Richard, G
    LANCET, 1999, 353 (9148): : 209 - 210
  • [22] AN OVERVIEW OF LIPID-LOWERING DRUGS
    ILLINGWORTH, DR
    DRUGS, 1988, 36 : 63 - 71
  • [23] Lipid-Lowering Drugs and Cataract
    Bezin, Julien
    Mansiaux, Yohann
    Pariente, Antoine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 555 - 555
  • [24] Lipid-lowering drugs and mortality
    Corrigan, F
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 : 289 - 289
  • [25] Semaglutide, lipid-lowering drugs, and NAFLD
    Katsiki, Niki
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 329 - +
  • [26] LIPID-LOWERING DRUGS, HYPOTHYROIDISM AND RHABDOMYOLYSIS
    GOUTON, M
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1993, 86 (12): : 1761 - 1764
  • [27] New Era of Lipid-Lowering Drugs
    Barter, Philip J.
    Rye, Kerry-Anne
    PHARMACOLOGICAL REVIEWS, 2016, 68 (02) : 458 - 475
  • [28] Lipid-Lowering Drugs and Circulating Adiponectin
    Wanders, Desiree
    Plaisance, Eric P.
    Judd, Robert L.
    ADIPONECTIN, 2012, 90 : 341 - 374
  • [29] PLASMA CARNITINE AND LIPID-LOWERING DRUGS
    NESTRUCK, AC
    PANDE, SV
    DAVIGNON, J
    ATHEROSCLEROSIS, 1985, 55 (03) : 353 - 356
  • [30] Lipid-lowering drugs in the management of hyperlipidaemia
    Bhatnagar, D
    PHARMACOLOGY & THERAPEUTICS, 1998, 79 (03) : 205 - 230
12345